Hostname: page-component-848d4c4894-mwx4w Total loading time: 0 Render date: 2024-06-28T10:01:09.450Z Has data issue: false hasContentIssue false

Diagnostics of the AML with immunophenotypical data

Published online by Cambridge University Press:  15 May 2008

A. Plesa
Affiliation:
Service d'Hématologie clinique, Hospices Civils de Lyon, 69003 Lyon, France
G. Ciuperca
Affiliation:
Université de Lyon, Université Lyon 1, CNRS UMR 5208 Institut Camille Jordan F - 69200 Villeurbanne Cedex, France
V. Louvet
Affiliation:
Université de Lyon, Université Lyon 1, CNRS UMR 5208 Institut Camille Jordan F - 69200 Villeurbanne Cedex, France
L. Pujo-Menjouet*
Affiliation:
Université de Lyon, Université Lyon 1, CNRS UMR 5208 Institut Camille Jordan F - 69200 Villeurbanne Cedex, France
S. Génieys
Affiliation:
Université de Lyon, Université Lyon 1, CNRS UMR 5208 Institut Camille Jordan F - 69200 Villeurbanne Cedex, France
C. Dumontet
Affiliation:
Service d'Hématologie clinique, Hospices Civils de Lyon, 69003 Lyon, France
X. Thomas
Affiliation:
Service d'Hématologie clinique, Hospices Civils de Lyon, 69003 Lyon, France
V. Volpert
Affiliation:
Service d'Hématologie clinique, Hospices Civils de Lyon, 69003 Lyon, France
Get access

Abstract

Patients with acute myeloblastic leukemia (AML) are divided according to the French American British (FAB) classification into eight subgroups (M0 to M7) on the basis of their degree of maturation/differentiation. However, even if immunophenotypical characterization by flow cytometry is routinely used to distinguish between AML and acute lymphoblastic leukemia (ALL), it is not yet well established for the identification within the AML subgroups. Here we show that certain subgroups of AML can be identified with a good accuracy (80% of the patients we analyzed) by means of the expression of specific markers.

Type
Research Article
Copyright
© EDP Sciences, 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)